Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux®

NCT01553032 is registered in ClinicalTrials.gov with University of Heidelberg Medical Center as lead sponsor.

NCT NCT01553032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01553032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux®
Lead sponsor
University of Heidelberg Medical Center
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
May 31, 2017
Enrollment
139 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer